Corporate Website
Africa
Argentina
Asia
Australia
Belgium
Brazil
Bulgaria
Canada (EN)
Chile
China
Colombia
Denmark
Egypt
France
Germany
Greece
Hungary
Indonesia
Italia
India
Japan
Korea
Malaysia
Mexico
Middle East
Netherlands
Peru
Philippines
Poland
Portugal
Romania
Russia
South Africa
Spain
Sweden
Thailand
Tunisia
Turkey
Ukraine
United Kingdom
USA
Vietnam
Hatchery of the year award >
"The one thing that differentiated H3 from the rest was ownership and the fact that they accepted the challenge from day one. The management were involved in every aspect of the process and managed to keep the personnel motivated. It is really pleasant to work with such a team" Chris van Biljon, Vaccine Services Manager, Ceva Animal Health.
94.7km Cycle Challenge – 15 Nov 2015 >
South Africa's second largest timed race.
AVI - AFRICA 2015 >
Ceva wins “Best Large Stand Award”
Beef Farming School >
“Alignment between Veterinarian and Farmer on all aspects of Beef Reproduction to optimize kg beef yield per hectare”
Dairy Farming School >
This was a gathering of top Dairy Veterinarians and Dairy Farmers to discuss the benfits and conditions needed for ideal fixed time AI success.
Privexia® Launch >
It’s our great pleasure to announce the launch of Privexia® , the new endectocide from Ceva Animal Health Reg. No. G3915 (Act 36/1947). Privexia® contains 1% Moxidectin , a second generation macrocyclic lactone, with a broad spectrum of activity against both internal and external parasites. Privexia® is registered with 35 days persistent action for the control of sheep wireworm and brown stomachworm...
Monitoring the intake of a gumboro immune-complex vaccine administered in the hatchery. >
Its use and examples compared to the classical vaccination method.
The Relevance of Bursa Size in modern Poultry Production >
Author: Kobus van Heerden, Technical Marketing Manager – CEVA Santé Animale Co-Authors: Dr. Christophe Cazaban, Innovation Strategy Biology Business Unit - CEVA Santé Animale Dr. Branko Alva, Corporate Product Manager - CEVA Santé Animale
Ceva conducts Global Vector Vaccine Symposium >
Ceva, a global leader in vector vaccines technology, hosted over 280 participants from 41 countries at its first Vector Vaccine Symposium on October 06-08, 2010.
C.H.I.C.K. Programme >
Clinical Traits and Pathology of Newcastle Disease Infection and Guidelines for Farm Visit and Differential Diagnosis